Veracyte (VCYT) Shares Outstanding (Diluted Average) (2019 - 2026)

Veracyte has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $81.3 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $81.3 million, up 1.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.3 million (up 1.57% YoY), and the FY2025 annual result was $80.6 million, up 3.08% from the prior year.
• Shares Outstanding (Diluted Average) came in at $81.3 million for Q1 2026 at Veracyte, up from $80.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $81.3 million in Q1 2026 to a low of $71.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $74.8 million (2024), against an average of $75.6 million.
• Across the five-year window, Shares Outstanding (Diluted Average) increased 12.47% in 2022 and rose 1.16% in 2023, its largest moves.
• Veracyte's Shares Outstanding (Diluted Average) stood at $71.5 million in 2022, then climbed by 1.53% to $72.6 million in 2023, then rose by 7.6% to $78.2 million in 2024, then gained by 3.08% to $80.6 million in 2025, then gained by 0.92% to $81.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $81.3 million (Q1 2026), $80.6 million (Q4 2025), and $79.9 million (Q3 2025), per Business Quant data.